World-class team, stellar science and a platform still searching for target classes where mechanistic clarity actually compounds into clinical advantage
Eikon Tx: thoughts on the IPO of a techbio…
World-class team, stellar science and a platform still searching for target classes where mechanistic clarity actually compounds into clinical advantage